Skip to main content

Jefferies Financial Group Inc.

Source: SEC Form 13F · as of Mar 2026

Jefferies Financial Group Inc. holds 65 biotech & pharma companies tracked by BioSniper, totaling $407.6M in value as of Mar 2026 (SEC Form 13F).

Companies held

65

Total value held

$407.6M

BioSniper AIPage evidence connected

Prepared research question

What matters most for PTC THERAPEUTICS, INC. (PTCT)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
PTCTPTC THERAPEUTICS, INC.1,354,459$92.3M
IMTXImmatics N.V.5,059,551$49.8M
JAZZJazz Pharmaceuticals plc175,599$33.2M
BMRNBIOMARIN PHARMACEUTICAL INC468,146$26.4M
ARGXARGENX SE30,005$21.9M
DNTHDianthus Therapeutics, Inc. /DE/202,410$17.0M
CTMXCytomX Therapeutics, Inc.3,067,864$14.4M
GILDGILEAD SCIENCES, INC.89,485$12.5M
REGNREGENERON PHARMACEUTICALS, INC.13,481$10.4M
GHRSGH Research PLC712,300$10.0M
ABCLAbCellera Biologics Inc.2,746,200$9.6M
MLTXMoonLake Immunotherapeutics500,000$9.3M
APLSApellis Pharmaceuticals, Inc.219,000$8.8M
ABUSArbutus Biopharma Corp1,894,067$8.5M
ALNYALNYLAM PHARMACEUTICALS, INC.25,553$8.5M
CMPSCOMPASS Pathways plc1,467,362$8.1M
INCYIncyte Corp.66,853$6.3M
BBIOBridgeBio Pharma, Inc.82,300$6.1M
KALVKalVista Pharmaceuticals, Inc.286,046$5.8M
IONSIONIS PHARMACEUTICALS INC59,065$4.4M
ZBIOZenas BioPharma, Inc.219,947$4.3M
SABSSAB BIOTHERAPEUTICS, INC.903,094$3.5M
CAPRCAPRICOR THERAPEUTICS, INC.104,361$3.2M
GPCRStructure Therapeutics Inc.62,592$3.0M
AXSMAxsome Therapeutics, Inc.15,500$2.6M
KODKodiak Sciences Inc.66,269$2.5M
EXELEXELIXIS, INC.56,200$2.4M
IBRXImmunityBio, Inc.300,000$2.3M
COGTCogent Biosciences, Inc.55,574$2.1M
SMMTSummit Therapeutics Inc.100,000$1.9M
ONCBeOne Medicines Ltd.6,200$1.8M
LGNDLigand Pharmaceuticals Incorporated7,315$1.5M
ABVXAbivax SA10,153$1.1M
ATAIAtai Beckley N.V.275,900$977K
MRNAModerna, Inc.19,000$965K
TEVATeva Pharmaceutical Industries Limited31,564$951K
ANIPANI PHARMACEUTICALS INC12,000$923K
RGNXREGENXBIO Inc.95,400$799K
CATXPerspective Therapeutics, Inc.183,342$765K
DNLIDenali Therapeutics Inc.34,425$661K
SNYSanofi12,363$596K
FOLDAMICUS THERAPEUTICS, INC.40,300$583K
INSMINSMED Inc3,500$572K
STOKStoke Therapeutics, Inc.16,300$531K
XERSXeris Biopharma Holdings, Inc.87,800$509K
CHRSCoherus Oncology, Inc.252,000$426K
ALTAltimmune, Inc.110,000$339K
SIGASIGA TECHNOLOGIES INC62,667$335K
OGNOrganon & Co.51,950$311K
RVMDREVOLUTION MEDICINES, INC.2,490$242K
KNSAKiniksa Pharmaceuticals International, plc5,000$241K
ROIVRoivant Sciences Ltd.7,266$201K
TVTXTravere Therapeutics, Inc.4,837$144K
OCGNOcugen, Inc.75,917$137K
RLMDRELMADA THERAPEUTICS, INC.16,120$112K
LXRXLEXICON PHARMACEUTICALS, INC.68,734$107K
OLMAOlema Pharmaceuticals, Inc.7,000$104K
IVVDInvivyd, Inc.65,520$85K
PROKPROKIDNEY CORP.46,398$83K
XFORX4 Pharmaceuticals, Inc19,474$80K
LCTXLineage Cell Therapeutics, Inc.44,192$70K
CCCCC4 Therapeutics, Inc.26,120$69K
BDTXBlack Diamond Therapeutics, Inc.16,208$35K
GALTGALECTIN THERAPEUTICS INC12,188$34K
NTLAIntellia Therapeutics, Inc.1,000$13K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.